These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28848920)

  • 1. The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.
    Tabberer M; Benson VS; Gelhorn H; Wilson H; Karlsson N; Müllerova H; Menjoge S; Rennard SI; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):112-123. PubMed ID: 28848920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
    Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
    [No Abstract]   [Full Text] [Related]  

  • 3. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.
    Müllerova H; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Rennard SI; Tabberer M; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):141-149. PubMed ID: 28848923
    [No Abstract]   [Full Text] [Related]  

  • 4. Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.
    Jones PW; Gelhorn H; Wilson H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):124-131. PubMed ID: 28848921
    [No Abstract]   [Full Text] [Related]  

  • 5. The COPD Biomarkers Qualification Consortium St George's Respiratory Questionnaire Manuscripts: Output of a Consortium to Advance Drug Development.
    Tabberer M; Jones PW
    Chronic Obstr Pulm Dis; 2017 Feb; 4(2):109-111. PubMed ID: 28848919
    [No Abstract]   [Full Text] [Related]  

  • 6. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
    Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
    Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's New with the St George's Respiratory Questionnaire and Why Do We Care?
    Hardin M; Rennard SI
    Chronic Obstr Pulm Dis; 2017 Apr; 4(2):83-86. PubMed ID: 28848916
    [No Abstract]   [Full Text] [Related]  

  • 8. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
    Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and clinical interpretation of the St George's respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD.
    Rehman AU; Hassali MAA; Harun SN; Abbas S; Muneswarao J; Ali IABH; Hussain R
    Health Qual Life Outcomes; 2020 May; 18(1):138. PubMed ID: 32404113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
    Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.
    Wilke S; Smid DE; Spruit MA; Janssen DJA; Muris JWM; van der Molen T; van den Akker M; Jones PW; Wouters EFM; Franssen FME
    Chronic Obstr Pulm Dis; 2014 Sep; 1(2):212-220. PubMed ID: 28848823
    [No Abstract]   [Full Text] [Related]  

  • 16. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
    Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
    Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.
    Loubert A; Regnault A; Meunier J; Gutzwiller FS; Regnier SA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2103-2113. PubMed ID: 32982203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.
    Rutten-van Mölken M; Roos B; Van Noord JA
    Thorax; 1999 Nov; 54(11):995-1003. PubMed ID: 10525558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.